X4 Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Corporate Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/3/2026

1. CRWD
2. REGN
3. LITE
4. AAPL
5. ABBV
6. MRVL
7. CL
8. LYB
9. TFII
10. ORCL

Go back to X4 Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Corporate Update

X4 Pharmaceuticals (XFOR) Tops Q2 EPS by 3c

August 4, 2022 7:18 AM EDT

X4 Pharmaceuticals (NASDAQ: XFOR) reported Q2 EPS of ($0.60), $0.03 better than the analyst estimate of ($0.63).

X4 had $48.7 million in cash, cash equivalents, and restricted cash as of June 30, 2022. On June 30, 2022, the company announced a private equity financing (PIPE) of approximately $56 million before deducting offering... More